banner
 
Home      Research      About us      Publications      Services      Public      Contacts      Search

space

In this section

 In this section


 

MRC home
line
MRC research
line
HIV and AIDSline
HIV Prevention Research Unit
line
South African AIDS Vaccine Initiative
line
Tuberculosisline
TB Epidemiology and Intervention Research Unit
line
Clinical and Biomedical Tuberculosis Research Unit
line
Molecular Mycobacteriology Research Unit line
Centre for Molecular and Cellular Biology
line
Cardiovascular Disease and Diabetes
line
Chronic Diseases of Lifestyle Research Unit
line
Inter-university Cape Heart Research Unit
line
Exercise Science and Sports Medicine Research Unit

line
Infectious Disease
line
Immunology of Infectious Disease Research Unit
line
Diarrhoeal Pathogens Research Unit

line
Inflammation and Immunity Research Unit
line
Respiratory & Meningeal Pathogens Research Unit
line
Malaria Research Unit
line
Safety and Peace Promotionline
Safety and Peace Promotion Research Unitline
Cancer
line
Cancer Epidemiology Research Unit

line
PROMEC
line
Oesophageal Cancer Research Unit
line
Oncology Research Unit
line
Public Health
line
Burden of Disease Research Unit
line
Biostatistics Unit
line
SA Cochrane Centre
line
Health Policy Research Unit
line
Health Systems Research Unit
line
Rural Public Health & Health Transition Research Unitline
Health Promotion
line
Alcohol & Drug Abuse Research Unit

line
Health Promotion Research and Development Research Unit
line
Women, Maternal and Child Health
line
Gender and Health Research Unit

line
Maternal and Infant Health Care Strategies Research Unit
line
Nutritionline

Nutritional Intervention Research Unit
line
Brain and Behaviour
line
Anxiety and Stress Disorders Research Unit
line
Medical Imaging Research Unit

line
Genomics and Proteomicsline

Bioinformatics Capacity Development Research Unit
line
Human Genetics Research Unit
line
Receptor Biology Research Unitline
Environment and Health
line

Environment & Health Research Unit
line
South African Traditional Medicine
line
Drug Discovery and Development Research Unitline
Indigenous Knowledge Systems Research Unit

 


Terms and Conditions
to visit this site

bullet

 Our research 

PROMEC Unit

Publications

Publications 2009

  1. Abel S, De Kock M, Van Schalkwyk DJ, Swanevelder S, Kew MC, Gelderblom WCA (2009). Altered lipid profile and oxidative status in human hepatocellular carcinoma. Prost Leukot Essential Fatty Acids 81, 391–39.  (Indexed. Impact factor 1.366).
  2. Alberts JF, Gelderblom WCA, Botha A, van Zyl WH (2008). Degradation of aflatoxin B1 by fungal laccase enzyme.  Int J Food Microbiol 135 (2009) 47–52. (Indexed. Impact factor 2.581).
  3. Botes A, Boekhout T, Hagen F, Vismer HF, Swart J, Botha A (2009). Growth and sporulation of Cryptococcus neoformans variety grubii on woody debris. Microbial Ecology 57(4): 757-65.  (Indexed. Impact factor 2.558).
  4. Ghiasian SA, Aghamirian MR, Adibpour M, Shephard GS, van der Westhuizen L. (2009). Occurrence of fumonisins in maize imported into Iran during 2001-2002. Mycotoxin Research 25: 25-28. (Not Indexed).
  5. Hon GM, Hassan MS, Janse van Rensburg S, Abel S, Van Jaarsveld P, Erasmus RT, Matsha T. (2009) Red blood cell membrane fluidity in the aetiology of Multiple Sclerosis. Journal of Membrane Biology 232:25-34.
  6. Hon G, Hassan M, Janse van Rensburg S, Abel S, Marais De Wet, van Jaarsveld P, Smuts C,  Henning F,  Erasmus R, Matsha T. (2009). Erythrocyte membrane fatty acids in patients with multiple sclerosis. Multiple Sclerosis 15: 759-762. (Indexed. Impact factor 3.260).
  7. Hon, G.M., Hassan, M.S. van Rensburg, S.J. Abel, S. Marais, De W. van Jaarsveld, P. Smuts, C.M. Henning, F. Erasmus, R.T. and Matsha. T. (2009). Immune cell membrane fatty acids and inflammatory marker, c-reactive protein in patients with multiple sclerosis. British Journal of Nutrition 19, 1-7. (Indexed. Impact factor 2.764).
  8. Joubert E, Gelderblom WCA, de Beer D (2009).  Phenolic contribution of South African herbal teas to a healthy diet. Natural Product Communications 4: 701-718. (Indexed. Impact factor 0.435)
  9. Liu M, Katerere DR, Gray AI, Seidel V. (2009) Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma. Fitoterapia 80, 369–373. (Indexed. Impact factor 1.200)
  10. Marnewick JL, van der Westhuizen FH, Joubert E, Swanevelder S, Swart P, Gelderblom WCA (2009). Chemoprotective properties of rooibos (Aspalathus linearis), honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas against cancer promotion induced by fumonisin B1 in rat liver. Food Chem Toxicol 47: 220-229. (Indexed. Impact factor 2.321).
  11. Ndube N, van der Westhuizen L, Shephard GS. 2009. Determination of fumonisins in maize by HPLC with ultraviolet detection of o-phthaldialdehyde derivatives. Mycotoxin Research 25, 225-228.
  12. Nguefack J, Lekagne Dongmo JB, Dakole CD, Leth V, Vismer HF, Torp J,  Guemdjom EFN, Mbeffo M, Tamgue O, Fotio D, Amvam Zollo PH, Nkengfack AE (2009). Food preservative potential of essential oils and fractions from Cymbopogon citratus, Ocimum gratissimum and Thymus vulgaris against mycotoxigenic fungi. International Journal of Food Microbiology. (Indexed. Impact factor 2.581).
  13. Shephard GS, Berthiller F, Dorner J, Krska R, Lombaert GA, Malone B, Maragos C, Sabino M, Solfrizzo M, Trucksess MW, Van Egmond HP, Whitaker TB (2009). Developments in mycotoxin analysis: an update for 2007 - 2008. World Mycotoxin Journal 2: 3-21. (Not indexed).
  14. Shephard GS (2009). AOAC General Referee Report: Mycotoxins. J AOAC Int 92: 1B-2B. (Indexed. Impact factor 1.352).
  15. Shephard GS. Book Review, Food Contaminants: Mycotoxins and Food Allergens, ACS Symposium Series 1001, Edited by D.P. Siantar, M.W. Trucksess, P.M. Scott, and E.M. Herman, American Journal of Human Biology 21: 711-712. (Indexed. Impact factor 1.976).
  16. Shephard GS (2009) Aflatoxin analysis at the beginning of the 21st century. Anal Bioanal Chem 395, 1215-1224. (Indexed. Impact factor 2.867).
  17. Snijman P, Joubert E, Ferreira D, Li X, Ding Y, Green I, Gelderblom W (2009) Antioxidant Activity of the Dihydrochalcones, Aspalathin and Nothofagin, and Their Corresponding Flavones in Relation to Other Rooibos (Aspalathus linearis) Flavonoids, EGCG, and Trolox. J Agric Food Chem. 57, 6678–6684. (Indexed. Impact factor 2.562).
  18. Steyn PS, Gelderblom WCA, Shephard GS, Van Heerden FR (2009). Mycotoxins with special focus on aflatoxins, ochratoxins and fumonisins. General and Applied Toxicology. Third Edition, Ballantyne, B., Marrs, T. and Syversen, T. (eds). John Wiley & Sons Ltd, Chichester, UK. Pp 3467-3527. (Not indexed. Book chapter).

Book Chapters

  1. Gelderblom WCA, Gamieldien K, Joubert E (2009). Black and other teas. In Chemoprevention of Cancer and DNA Damage by Dietary Factors. Knasmuller S, DeMarini DM, Johnson I T, Gerhauser C. (Eds). Wiley-VCH Germany, pp, 609-633.

Manuscripts in Press

  1. Hon GM, Hassan MS, van Rensburg SJ, Abel S, Erasmus RT, Matsha T.  Membrane saturated fatty acids and disease progression in Multiple Sclerosis patients. Journal of Metabolic Brain Disease.
  2. Katerere DR, Luseba D. Ethnoveterinary Botanical Medicine:  Herbal medicines for Animal Health.  CRC Press (Not Indexed. Book)
  3.  Van der Merwe JD, Joubert, E, Manley M, de Beer D, Malherbe CJ, Gelderblom WCA.  In vitro hepatic biotransformation of aspalathin and nothofagin, dihydrochalcones, rooibos (Aspalathus linearis) and assessment of metabolite antioxidant activity.
  4. Somdyala NIM, Bradshaw D, Gelderblom WCA, Parkin DM (2009) Cancer incidence in a rural population of South Africa, 1998-2002. Int J Cancer.

Theses

1.       Gelderblom WCA. (2009) Mycotoxicological properties of Fusarium verticillioides and the fumonisins – mechanisms and implications for setting risk assessment parameters in humans. DSc, Department of Biochemistry, University of Stellenbosch.

Policy Briefs

1.       Rheeder JP, Shephard GS, Vismer HF, Gelderblom WCA. Guidelines on mycotoxin control in South African foodstuffs:  From the application of the Hazard Analysis and Critical Control Point (HACCP) system to new national mycotoxin regulation.  MRC Policy Brief, October 2009.

 

 

Contact the Webmaster
Last updated:
20 December, 2012
Home    Research     About us     Publications     Services     Public     Contacts     Search    Intranet